Media & News

Read more

Dr. Dominique Morisano: “Get a good set of headphones, and suggest the same for your clients”

One of the consequences of the pandemic is the dramatic growth of Telehealth and Telemedicine. But how can doctors and providers best care for their patients when they are not physically in front of them? What do doctors wish patients knew in order to make sure they are getting the best results even though they are not actually in the office? How can Telehealth approximate and even improve upon the healthcare that traditional doctors’ visits can provide?

Read more

California Senate Approves Bill To Legalize Possession Of Psychedelics Like Psilocybin And LSD

A bill to legalize possession of psychedelics in California was approved by the California Senate on Tuesday. The legislation, sponsored by Sen. Scott Wiener (D), which previously cleared three committees, passed 21-16 on the floor.

Read more

I Was Paralyzed by Severe Depression. Then Came Ketamine.

Read more

Turn On, Tune In, Feel Better: The Rise of Psychedelic Therapy in Texas

On the day it opened in early May, Field Trip Health’s therapeutic facility in Houston’s uptown neighborhood looked a little like a high-end strip-mall spa. Dressed in a floral shirt, Matt Emmer, the company’s director of operations and business development, showed me the clinic’s amenities. Field Trip, which launched in 2019 in Toronto and began opening clinics across North America in 2020, offers patients what is currently the only psychedelic drug with Food and Drug Administration approval for prescription: the anesthetic ketamine.

Read more

What Is Psychedelic Assisted Therapy?

Ketamine assisted psychotherapy is now approved for use in Canada, so yes, it is safe. Ketamine is the only psychedelic approved in Canada for use in treatment-resistant depression, though it’s been around since the 50’s. It’s a super fast-working therapy that has shown significant improvement in patients in just 24 hours! It can also be co-prescribed with other antidepressants for a more profound effect.

Read more

Exploring the Modern Emergence of Psychedelic-Assisted Psychotherapy

One company pioneering the ketamine-assisted psychotherapy movement across North America is the psychedelic pioneers at Field Trip Health. They have opened several clinics across Canada and North America that, unlike other ketamine clinics, incorporate compassionate and comprehensive psychotherapy into the process. This guide explores their cutting-edge ketamine-assisted psychotherapy program for prospective clients and psychedelic enthusiasts alike.

Read more

There is a Lot of Fungus Among Us

“As a food, mushrooms have a lot of things going for them in terms of their nutritional value,” said Joshua Lambert, a co-director of the Center for Plant and Mushroom Foods for Health at the Penn State College for Agricultural Sciences. “But one of the things we’re looking into are the other compounds that mushrooms and other plants have that may have significant health benefits.”

Read more

TV Doctor to Offer Ketamine Therapy at Santa Monica Clinic

Mike Dow, host of TLC's 'Freaky Eaters,' has joined Field Trip Health, which describes ketamine as a protocol "designed to help those suffering from treatment-resistant depression, generalized anxiety disorder and trauma."

Read more

Microdosing, a Placebo Effect

A recent study found that microdosing psychedelic drugs had beneficial psychological effects – but so did a placebo. That might seem like a dose of cold water for this promising area of mental health treatment, but DLSPH Adjunct Prof. Dr. Dominique Morisano, Chief Psychologist at Field Trip Health, sees it differently.

Read more

Psychedelics are Transforming the way we Understand Depression and its Treatment

The most exciting aspect of this trial is a sense that we are on the verge of a paradigm shift in mental healthcare linked to an improved understanding of the origins of depression, and how we can most effectively treat it. In my view, this shift will take us away from an outdated and myopic “drug-alone” perspective that has dominated psychiatry for several decades, and towards a multi-level “biopsychosocial” model.

Read more

Why LSD is poised for a comeback as treatment for substance abuse, anxiety and depression

It’s been almost 80 years since that fateful first acid trip but it looks as if Hofmann’s “problem child” might be getting past the bumpy road stage and growing up to face a promising future. Which makes this Bicycle Day one of LSD’s best birthdays ever. At least so far.

Read more

In Canada, psychedelics re-emerge in treatment of depression

To manage her stress and fears, Andrea Bird -- who is suffering from terminal cancer -- uses psychedelics, which are seeing a sudden re-emergence in Canada as a possible treatment for mental health conditions such as anxiety and depression. The 60-year-old Canadian was diagnosed with breast cancer in 2012. Despite aggressive treatment, the disease returned five years later, spreading to her lungs, bones and brain.

Read more

Toronto company to conduct Jamaica's first psilocybin clinical trial for managing depression

“We are confident that this state-of-the-art facility and partnership with Field Trip will foster a wealth of innovation for the future of mental health research and therapies, even as we contribute to the regulatory framework that the Government of Jamaica (GOJ) is currently developing,” said Dale Webber, a professor, pro-vice-chancellor and principal at UWI.

Read more

Field Trip’s Dr. Ben Medrano: How Ketamine Works On Depression

Dr. Ben Medrano is psychiatrist and the medical director of Field Trip Health America. In an interview with The Dales Report last week, he shared some of the reasons behind his interest in the field of psychedelic-assisted psychotherapy, as well as some information about depression and the treatment available at Field Trip’s New York location.

Read more

Field Trip Secures $76M For Psychedelics Clinics, Drug Development

Field Trip Health announced Wednesday the closing of a CA$95 million ($76.5 USD million) offering. The raise is one of the largest in the sector’s history, and puts Field Trip’s cash on hand at roughly CA$113.7 million ($91.5 USD million).

Read more

Psychedelic Therapy Needs to Confront the Mystical

Many people have a spiritual experience on psychedelics. How they make meaning of it could be influenced by the metaphysical beliefs of their therapists.

Read more

Will the Federal Government Finally Embrace the Psychedelic Revolution?

From approving religious exemptions to budgeting for medical research, advocates are hopeful that Biden and a Democratic Congress could mean progress for psilocybin and other therapeutic psychedelics

Read more

World’s first research and cultivation facility for psilocybin-producing mushrooms opens in Jamaica

The world’s first legal research and cultivation facility dedicated to psilocybin-producing mushrooms and other plant-based psychedelics has opened in Mona, Jamaica. The facility, Field Trip Natural Products Limited Research and Development Laboratory for Psychedelic Fungi, is in partnership with Toronto-based Field Trip Health Ltd. and the University of West Indies (UWI).

Read more

World’s first research and cultivation facility for psychedelic mushrooms

A new partnership will see the world’s first legal research and cultivation facility dedicated exclusively to psilocybin-producing mushrooms and other plant-based psychedelics.

Read more

UWI Mona partners with mushroom-research firm Field Trip Ventures

The University of the West Indies (UWI), Mona, has entered into a partnership with Canadian company Field Trip Ventures Inc., in a new research facility dedicated to psychedelic fungi. Field Trip Natural Products (Ja) Limited Research and Development Laboratory, was formally launched on Tuesday, February 9, 2021, in an event held at the Faculty of Science and Technology at the UWI.

Read more

Protecting People From the Side Effects of Psychedelic Therapy

We’re in a shroom boom. One company, Compass Pathways, which plans to offer magic mushroom therapy, listed on the Nasdaq in November with a $1 billion valuation. New funds like Atai are raising hundreds of millions to invest in psychedelics. New companies are listing, new training programmes for therapists are launching, new states are preparing to legalize or decriminalize psychedelics.

Read more

How Ecstacy and Psilocybin are Shaking up Psychiatry

Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.

Read more

5 Athletes Who Healed With Psychedelic Therapy

Researchers say psychedelics like ayahuasca, psilocybin, ketamine, ibogaine and 5-MeO-DMT prove so beneficial to professional athletes because they have the ability to heal. The sacrifice athletes of high-impact sports make to succeed goes beyond the personal and physical. Researchers have found that repeated head blows and concussions can have detrimental long-term effects on the brain—headaches, dizziness, forgetfulness, insomnia, anxiety, depression, aggression, and in some cases, the desire to kill oneself or others.

Read more

Canadian Military Veteran, Master Corporal Scott Atkinson, Submits Request to Minister of Health, Hon. Patty Hajdu, to Access Proven Psilocybin-Assisted Psychotherapy For Non-Palliative Use

Master Corporal Scott Atkinson, a 25-year Canadian military veteran, today made an application to Health Canada for an exemption under Section 56 of The Controlled Drugs and Substances Act to access psilocybin-assisted psychotherapy to treat his depression and other mental health conditions resultant from his long and distinguished military career, including active tours in the former Yugoslavia and Afghanistan.

Read more

These 5 Apps Are Made for Taking Psychedelics

Are apps the secret to better psychedelic experiences? Psychedelics advocates love to call substances like ayahuasca an “ancient technology.” Perhaps it’s due to the futuristic visions you see while under the influence; maybe the intensive focus on the present moment feels so new that you assume a crafty engineer has designed the experience. Regardless, cosmonauts know well the sensation of time distortion.

Read more

Ketamine may Ease Depression by Restoring the Brain’s Sensitivity to Prediction Error, Study Suggests

New research suggests that electrophysiological brain signals associated with neural plasticity could help explain the rapid, antidepressant effects of the drug ketamine. The findings, European Neuropsychopharmacology, indicate that ketamine could reverse insensitivity to prediction error in depression.

Read more

What Psychedelics Taught me About Healing Trauma

It has been a tumultuous year for the world at large, with COVID-19 necessitating sweeping changes to ways of life across nearly every geography and domain. Against this challenging backdrop, psychedelic medicine has gained a great deal of traction in 2020. Research and development—including clinical trials—has continued to gain momentum and maturity, while public opinion, regulatory bodies, and mainstream media outlets all appear to be increasingly amenable to the prospect of psychedelic medicines and therapies.

Read more

Understanding The Psilocybin Supply Chain

Psilocybin is known as the active compound in so-called “magic mushrooms”, yet most psilocybin used in clinical trials today is synthesized in laboratories without the use of biological material. As psychedelics-assisted therapy gains momentum, investors need to understand the difference between the current available means of obtaining psilocybin. Field Trip Health's Director of Research joins Benzinga to discuss future pathways & opportunities in the space.

Read more

MLAngelo: Field Trip Health Touches Down in Santa Monica to Tackle Depression & Anxiety with Psychedelic Therapies

Using talk therapy and supervised ketamine sessions to help patients battle anxiety and depression, Field Trip Health is leading the psychedelic-enhanced psychotherapy movement across the United States.

Read more

Truffle Report: Field Trip Health Expands into Dutch Truffle Market

Read more

Dribbble: An illustrator’s advice for breaking into the digital product space

Fran Pulido As an illustrator, you may have never dreamed of seeing your work published in an app. It’s time to overcome this prejudice. In this post, illustrator Fran Pulido explains how to shine in the digital product space — a world constantly demanding visually amazing experiences and talent — and uses the Trip App as a case study for excellence.

Read more

Psyched: German Government Funds Psilocybin Study, Field Trip Opens Psilocybin Clinic

Field Trip Health Ltd. has signed a lease to open its first psychedelics-assisted therapy clinic in The Netherlands. This will be the first Field Trip clinic to offer psilocybin treatment, leveraging the fact that mushroom truffles containing psilocybin are not criminalized in The Netherlands.

Read more

Cannabis Culture: Field Trip (Ten Years of Therapy in an Afternoon?)

According to Independent Consultant Mort Goldman, Pharm.D., “Ketamine is relatively short-acting, with an incredibly high level of safety. That’s why it’s a favorite among doctors as a procedural anesthetic.” That’s also why ketamine seems like one of the most reasonable solutions to treating mental and emotional distress in a time when few have access to—or money for—extended psychotherapy sessions that can stretch out for years.

Read more

Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health

Field Trip Health Ltd., a global leader in the development and delivery of psychedelic therapies, and WHOOP, the human performance company, today announced a partnership whereby Field Trip will be using WHOOP Strap 3.0 to measure the biometric effects of Field Trip’s psychedelic therapies.

Read more

LA Weekly: Field Trip Health Expands Psychedelic-Assisted Therapy Options in L.A.

As lockdown continues to put conversations about people’s mental health into the spotlight, Los Angeles-based opportunities to partake in psychedelic-assisted therapy are growing.

Read more

New Program Brings Ketamine-Assisted Psychotherapy to Canadian Vets

For many veterans of war, the battle continues even after they’ve returned home from combat. The Veterans Affairs Canada website estimates that up to 10% of their warzone veterans will suffer from PTSD or another mental health affliction, and are 14-19% more likely than the general Canadian population to commit suicide, according to their 2019 Veteran Sucide Report. While both medications and therapeutic interventions are available for this condition, they haven’t proven very effective.

Read more

Update on Field Trip’s Jamaica Facility – Architectural Renders Released Update on Field Trip’s Jamaica Facility – Architectural Renders Released

Field Trip Health has shared renderings of their Jamaican facility with Psilocybin Alpha.

Read more

Oregon becomes first state to legalize magic mushrooms as more states ease drug laws in ‘psychedelic renaissance’

Oregon on Wednesday became the first state to legalize the active ingredient in so-called magic mushrooms on an election night that saw more states ease restrictions on drugs across the country.

Read more

Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development

Field Trip, the leader in the development and delivery of psychedelic therapies, today provided an update on its in-vivo and in-vitro studies on FT-104, its lead drug candidate.

Read more

Field Trip Health Ltd. Continues Expansion With Psychedelic-Enhanced Therapy Center in Chicago

CHICAGO, Oct. 22, 2020 -- Field Trip announces today the opening of their Chicago center. Located at 325 West Huron Street, Suite 603, the Chicago location is the fourth Field Trip Health center to open this year, following Toronto, New York and Los Angeles.

Read more

NYC Now Has a (Legal) Psychedelic Clinic for Mental Health

Earlier this week, it was announced that the U.S.-Canada border will remain closed for at least another month amid the spread of COVID-19. Luckily, one of their most useful exports at this particular moment now has a home in the U.S.: the psychedelically enhanced therapy clinic Field Trip Health just opened its first stateside location in Manhattan. The Canadian company opened its flagship clinic in Toronto back in March, calling itself “the world’s first mental wellness company focused on psychedelics and psychedelic-enhanced psychotherapy.” And while the concept of psychedelically enhanced therapy isn’t itself new (you’ve probably heard about Silicon Valley’s obsession with microdosing), the ability of companies like Field Trip or Ember Health to create a sense of normalcy around the practice certainly is.

Read more

Heroic Hearts Project and Field Trip Health Ltd. enter into a strategic relationship to increase legal psychedelic therapy access for military veterans in North America

Heroic Hearts Project ("HHP"), an international nonprofit organization that connects military veterans struggling with mental trauma to psychedelic therapies, and Field Trip Health Ltd. (CSE: FTRP) ("Field Trip"), the global leader in the development and delivery of technology-enabled psychedelic therapies, today announced entry into a strategic relationship to increase access to, and awareness of, psychedelic therapies for veterans suffering from mental health disorders such as PTSD.

Read more

Field Trip Adds Acclaimed Physician, Dr. Andrew Weil, to Medical Advisory Board

Field Trip Health Ltd. announces the addition of Andrew Weil, M.D., world-renowned leader and pioneer in the field of integrative medicine, to its medical advisory board. In this role, Dr. Weil will provide Field Trip with medical advice and expertise on healing-oriented approaches to healthcare, as well as guidance on extending the influence and reach of psychedelic therapies.

Read more

Field Trip Psychedelics RTO Provides Exciting New Investing Option

After feasting on two new public companies, psychedelics investors will now get a new item on the menu: Field Trip Psychedelics. Field Trip announced its RTO date after market close on Friday. It is preparing to merge with shell company, Newton Energy Corporation (CAN:NTN.H).

Read more

Field Trip Health Ltd. to Commence Trading on the CSE on October 6 Under Ticker Symbol FTRP

Field Trip Health Ltd. is pleased to announce that its common shares will commence trading on the Canadian Securities Exchange (the "CSE") under the symbol FTRP tomorrow, October 6, 2020.

Read more

'Psyched': Field Trip Unveils Novel Compound, Numinus Begins Magic Mushroom Production

Field Trip Psychedelics Inc. announced Tuesday the successful synthesis of FT-104, a novel compound that is believed to have psychedelic capabilities. The conclusion comes after in-vitro and in-vivo tests confirmed that FT-104 interacts with the 5HT2A receptor, which is the main antagonist targeted by classic psychedelic drugs like LSD, psilocybin and mescaline.

Read more

Are Psychedelics Right For You?

The bottom line is that more and more ordinary people who may have never considered such a thing are willing to try psychedelics. And there are more and more companies emerging to help them. One is Field Trip Health, a company offering supervised in-clinic psychedelics experiences, using ketamine for psychotherapy. On their website, anyone can fill out a survey online about who they are and what they are looking for in their own mental health improvement efforts to see if they fit the criteria for psychedelics therapy.

Read more

Field Trip Health Ltd. Completes Reverse Take-Over Transaction and Prepares for Listing on the Canadian Securities Exchange

Field Trip Health Ltd. is pleased to announce that it has completed its previously announced reverse take-over of Field Trip Psychedelics Inc. ("FTP") by way of a three-cornered amalgamation (the "Transaction"). The Company will carry on the business of FTP, which is a global leader in the development and delivery of technology-enabled psychedelic therapies. Prior to the closing of the Transaction (the "Closing"), the Company changed its name to "Field Trip Health Ltd." and consolidated the outstanding common shares of the Company (each, a "Share"), on the basis of one post-consolidation Share for every eight pre-consolidation Shares.

Read more

Field Trip Psychedelics Inc. Introduces Trip, a Mobile App Designed to Expand Your Mind

Field Trip Psychedelics Inc. announces the launch of its first-ever app, Trip. A first-of-its-kind app and experience, Trip allows people from anywhere in the world to access tools that support self-exploration and consciousness expansion through meditation, breathwork and more.

Read more

Product Hunt: Trip. Take a trip. Expand your mind

While I have some reservations about rolling out psychedelic therapy to the masses, I'm also not in favor of restricting access to guides, information, and support for people who might be interested in exploring this avenue of self-help or self-discovery either. In an ideal world, there would ample human guides and assistance for people who are interested in chemically-assisted therapy, but alas, there's still too many taboos (and laws) to make such access readily available and stigma-free. Is an app a sufficiently safe way to provide access instead? Jury's out, but my hunch is no — nor do I think that's what Trip is trying to achieve. And yet here we are — and at least things are moving forward, providing access to support where previously there was little to none that was publicly readily available.